Phase 3 pivotal study: maximum concentration and time to maximum concentration
Phase 3 pivotal study: bracketing of exposure and consistency of time to maximum concentration
Phase 3 pivotal study: repeat dosing
Integrated phase 1 analysis: exposure and time to maximum concentration versus injected epinephrine
Phase 1 single ascending dose study: 12 mg film formulations versus EpiPen
Dose escalation and dose proportionality in the phase 1 study
Confirmatory pharmacokinetic study: self-administration versus clinician administration and manual intramuscular epinephrine
Confirmatory pharmacokinetic study: design and self-administration accuracy
Earlier self-administration pharmacokinetic study: time to maximum concentration
Effect of food: administration after a peanut butter sandwich
Effect of swallowing the film whole with water
Effect of water temperature and pH in the mouth
Effect of film placement and intraoral movement
Effect of tongue position: deliberate top-of-tongue and roof-of-mouth placement
Effect of hold time before swallowing saliva
Oral allergy syndrome: pharmacokinetics with and without oral allergen challenge
Oral allergy syndrome study: single-dose maximum concentration and time to maximum concentration
Oral allergy syndrome study: repeat-dose maximum concentration and time to maximum concentration
Oral allergy syndrome study: consistency of the absorption profile
Pediatric pharmacokinetics in participants aged 7 to 17 years
Comparison with nasal and oral alternatives to injected epinephrine